Average Co-Inventor Count = 2.67
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Precision Biologics, Inc. (13 from 29 patents)
2. Neogenix Oncology, Inc. (3 from 3 patents)
16 patents:
1. 12460013 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
2. 12344676 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
3. 11952429 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
4. 11572413 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
5. 11401341 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
6. 10364295 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
7. 10023650 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
8. 9605077 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
9. 9371375 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
10. 9169326 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
11. 8802090 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
12. 8535667 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
13. 8524456 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
14. 7829678 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
15. 7763720 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers